A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Inflammatory biomarkers of asymptomatic and symptomatic tuberculosis.
Awany D, Ariefdien DT, Mendelsohn SC, Rozot V, Mulenga H, Nyangu S, Tameris M, Moloantoa T, Katona A, Maruri F, Noor F, Panchia R, Hlongwane K, Stanley K, van der Heijden YF, Hadley K, Fiore Gartland A, Innes C, Brumskine W, Dheda K, Jaumdally S, Perumal T, Martinson N, Leslie A, Fourie B, Hiemstra A, Malherbe ST, Walzl G, Naidoo K, Churchyard G, Chegou NN, Sterling TR, Hatherill M, Scriba TJ, RePORT South Africa Study · Nat Commun (2026)
South Africa · DOI: 10.1038/s41467-026-75909-6
A large proportion of individuals with tuberculosis (TB) are asymptomatic. The biological and inflammatory underpinnings of asymptomatic TB are unknown and may differ from symptomatic TB. We characterise blood transcriptomic and proteomic profiles in South African community screening vs. health facility-based triage cohorts. Asymptomatic TB shares core transcriptomic and proteomic features with symptomatic TB, including upregulation of innate, interferon and inflammatory pathways and downregulation of T and B cell pathways. Integration of transcriptomic and proteomic data from asymptomatic TB individuals identifies two distinct sub-clusters characterized by higher or lower bacterial burden, blood IFN-γ responses, BMI, and chest radiographic abnormalities, suggesting different disease severity. We identify a new blood transcriptomic signature of asymptomatic TB. However, diagnostic performance of transcriptomic and proteomic markers is weaker for asymptomatic TB than symptomatic TB, suggesting that policy development for community-based, asymptomatic TB screening should not adopt biomarkers developed for symptomatic TB triage without further optimization.
Genomic Landscape of Systemic Lupus Erythematosus and Lupus Nephritis Globally and the Gaps in Africa.
Obadic BG, Katsukunya JN, Davidson B, Jones ESW, Hodkinson B, Freercks R, Dandara C, Mnika K · Int J Mol Sci (2026)
South Africa · DOI: 10.3390/ijms27167383
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a strong genetic component, and lupus nephritis (LN) represents one of its most common and severe organ-specific manifestations. This review synthesises current evidence on the genetic architecture of SLE and LN, with a particular focus on identifying shared and distinct genetic susceptibility loci and highlighting knowledge and data gaps in highly burdened African populations. Across studies, most risk loci, including HLA-DRB1, TNFSF4, IRF5, STAT4, TNFAIP3, BANK1, BLK, ITGAM, and FcγR2A/FcγR3A, converge on key immune pathways such as antigen presentation, type I IFN signalling, B-cell activation, and immune complex clearance. The findings support a substantial genomic overlap between SLE and LN, with most variants contributing to systemic immune dysregulation rather than kidney-specific susceptibility. A limited number of loci, including PDGFRA, HAS2, and SLC5A11, have been implicated in renal involvement, while APOL1 G1/G2 risk variants are associated with renal disease progression and adverse kidney outcomes among individuals of African ancestry. Despite these advances, relatively few loci have been definitively linked to LN independent of SLE, reflecting both biological overlap and limitations in study design. Moreover, the existing literature is heavily skewed toward European, Asian, and admixed populations, with minimal representation of continental African cohorts. Given the high genetic diversity and disproportionate disease burden in African populations, this represents a critical knowledge gap. Improved inclusion of diverse populations, coupled with high-resolution genomic and functional studies, will be essential to refine causal variant identification and enhance understanding of disease mechanisms. Ultimately, insights into population-specific genetic risk may enable earlier identification of high-risk individuals and support the development of precision medicine strategies for SLE, specifically LN.
Does the AMPD1 C34T Polymorphism Influence Physical Performance in Elite Athletes?
Martin DR, Stebbings GK, Heffernan SM, Erskine RM, Antrobus M, Brazier J, Lockey S, Jackson AL, Day S, Kilduff L, Bennett M, Raleigh SM, Cullen T, Collins M, Pitsiladis Y, Callus P, Herbert AJ, Williams AG · Genes (Basel) (2026)
South Africa · DOI: 10.3390/genes17080935
Background/Objectives: Adenosine monophosphate deaminase deficiency has been implicated in impaired exercise capacity. We examined whether the AMPD1 C34T (rs17602729) genotype was associated with athlete status and performance in distance runners (DRs) and rugby union (RU) athletes. Methods: Participants included 621 elite male RU athletes, 666 elite/sub-elite male and female DRs, and 1029 male and female non-athletes (NA), all of European ancestry. Genotyping was performed using real-time PCR with TaqMan reagents. Genotype and allele frequencies were compared using χ2 tests, while performance data were analysed using Kruskal-Wallis H, Mann-Whitney U, one-way ANOVA, and t-tests, with Benjamini-Hochberg correction applied for multiple comparisons. Results: Genotype and allele frequencies did not differ between athletes and NA or between athlete groups. In all DRs, run times did not differ between genotypes, although participants with the CT genotype in the elite and elite male subgroups were up to 5% faster than CC and TT homozygotes. In RU, participants with the CC genotype played 13% longer per appearance than those with the CT genotype, while forwards and front five participants with the CC genotype played 13% and 26% longer per appearance than T-allele carriers, respectively. Front five T-allele carriers made 75% more clean breaks than the front five with the CC genotype despite playing for a shorter time, although this finding should be interpreted cautiously. Conclusions: In summary, while the AMPD1 C34T genotype was not associated with athlete status, the CC genotype was associated with greater RU playing time per appearance in forwards, and the CT genotype was associated with superior performance in elite DRs.
Genotypes of Bovine Viral Diarrhea Virus Infecting Vaccinated and Nonvaccinated Cattle in Thrace District, Türkiye.
Karadag G, Tali HE, Ozkan IE, Turan N, Umar S, Richt JA, Yilmaz H, Yilmaz A · Viruses (2026)
South Africa · DOI: 10.3390/v18080807
Bovine viral diarrhea virus (BVDV) is a major cause of economic losses in the global cattle industry. This study investigated the clinical involvement and genetic diversity of BVDV in clinically affected cattle from the Thrace region in Türkiye, a critical border area with the European Union. A total of 533 nasal and rectal swabs were collected from 26 farms exhibiting clinical respiratory disease or diarrhea and analyzed using real-time RT-PCR. Positive samples were further characterized by sequencing and phylogenetic analysis to determine viral genotypes and subgenotypes. BVDV RNA was detected in 9 out of 26 farms (34.6%), with an overall positivity rate of 17.8% (95/533). Statistical analysis revealed significant associations between PCR positivity and both sampling year (p < 0.05) and animal age (p < 0.05). Genetic analysis of partial 5'-UTR sequences identified nine Pestivirus bovis subgenotype 1a strains, one Pestivirus bovis subgenotype 1f, and one Pestivirus brazilense. The Pestivirus bovis 1a strains clustered distinctly from previously reported Turkish BVDV-1 isolates, showing 97.32-99.11% nucleotide similarity with strains from Türkiye, Germany, China, Japan, the USA, Iran, and Argentina. Among the 533 samples tested, one Pestivirus brazilense isolate was identified, indicating its rare occurrence in the studied population despite targeted screening. This study represents the first report of Pestivirus brazilense in the Thrace region of Türkiye, expanding its known geographic range. The epidemiological data and genetic diversity analysis of BVDV strains characterized in this study offer critical insights for refining BVDV control programs, informing regional risk assessment, and supporting vaccine development.
Molecular characterization of Vibrio cholerae strains from clinical samples during the 2025 epidemic in the Republic of the Congo.
Baloki Ngoulou T, Pembe Issamou Mayengue, Makaya Dangui Nieko NP, Koukouikila-Koussounda F, Kaya-Ongoto DM, Eyenet Boussam DA, Lenguiya LH, Demboux Lyelet JE, Onyankouang IS, Diakouka Diambalou RC, Elenga RG, Kangoula-Dia-Kikoudi-Kia-Louzala F, Mouko M, Mounkala C, Dibantsa D, Mouellet WS, Louzolo I, Dzeret Indolo G, Dossou-Yovo LR, Niama FR · IJID Reg (2026)
Congo · DOI: 10.1016/j.ijregi.2026.100962
The study aimed to determine the bacteriological and molecular profile of Vibrio cholerae strains responsible for the cholera outbreak that occurred in July 2025 in the Republic of the Congo.
Fecal samples were collected from patients suspected of having cholera and admitted to health centers in four departments of the Republic of the Congo and sent to the National Public Health Laboratory for analysis. The samples were cultured, and the isolates obtained were subjected to serotyping and antibiotic susceptibility testing. Whole-genome sequencing was performed using the Illumina DNA Prep kit.
Of the 57 samples analyzed, 15 were phenotypically positive for V. cholerae O1 Ogawa and were confirmed by genotypic analysis. Phylogenetic analysis highlighted an epidemic clone closely related to Nigerian strains. The strains were resistant to ampicillin and nalidixic acid and sensitive to ciprofloxacin and doxycycline. All the strains carried the same resistance genes; however, one strain carried additional resistance genes. The virulence genes ctxA/B, tcpA/B, toxT, and zot were also identified in all the strains.
These results reveal the emergence of a virulent and multiresistant strain of V. cholerae O1 Ogawa in the Republic of the Congo, closely related to Nigerian strains. Its control requires cross-border coordination focused on genomic surveillance and mass vaccination.
Asian consensus on diagnostic algorithm for invasive pulmonary fungal diseases in high-burden settings.
Fang W, Liu X, Bilal H, Habib MD, Hanifi AN, Momin NWS, Lass-Flörl C, Samnang C, An L, Cao C, Chen M, Chen Z, Deng S, Fan L, Gong J, Gu B, Guo J, Huang X, Kang Y, Liang G, Lin L, Liu J, Liu W, Liu S, Liu W, Li Z, Li Z, Lu B, Lu Z, Ni Y, Qin X, Qiu H, Qu Y, Shi D, Shi Y, Su X, Tang H, Wang M, Wang Y, Wang J, Wu W, Xu B, Xu J, Xu Y, Ye F, Yu Y, Zhu L, Zhou L, Zong Z, Gemechu A, De Mandal S, Gaur P, Barchiesi F, Caggiano G, Abbasi B, Jamaati HR, Ganji SM, Ahmed SA, Alobaid K, Than LTL, Al-Hatmi AMS, Amir A, Mehmood I, Rahman M, Sudhadham M, İlkit M, Hoa PQ, Wang H, Nhung PH, Thi TD, Liao W, Huang X, Pan W · J Transl Int Med (2026)
Ethiopia · DOI: 10.1515/jtim-2026-0065
Invasive pulmonary fungal diseases (IPFD) continue to posing an increasing clinical and public health burden on immunocompromised populations. In many Asian settings, the diagnosis of IPFD faces substantial challenges driven by the high prevalence of comorbidities, including poorly controlled diabetes, tuberculosis (TB), and human immunodeficiency virus (HIV) infection, considerable heterogeneity in local pathogens, and disparities in access to diagnostic resources. To address these unmet needs, experts from 18 countries collaboratively developed this consensus, which provides a diagnostic algorithm tailored to high-burden Asian settings based on existing international and regional guidelines. When clinical manifestations are atypical or diagnostic clues are limited, the algorithm prioritizes evaluation for common and regionally prevalent IPFD, followed by stepwise expansion to other potential fungal pathogens. In addition, this consensus outlines the regional accessibility of different diagnostic modalities across Asia. This consensus focuses exclusively on optimization of the diagnostic algorithm and does not provide specific recommendations regarding antifungal therapy. Notably, improved diagnosis of IPFD through this algorithm may contribute to better patient outcomes and strengthened public health strategies in high-burden regions.
Using Lateral Flow Devices to Enhance Molecular Epidemiology and Evaluating the Rabies Surveillance System on Unguja Island, Zanzibar.
Bosch C, Moh'D AZ, Ramadhan RJ, Coetzer A, Malan AJ, Nel LH, Wright N · Viruses (2026)
Tanzania · DOI: 10.3390/v18080836
Dog rabies remains a neglected tropical disease in many resource-limited endemic regions, including Unguja Island, Zanzibar. Classically, in such resource-limited settings, an underestimation of the impact of rabies, which directly correlates with insufficient diagnostic capabilities and surveillance efforts, leads to poor investment in effective rabies control. This study combined molecular epidemiology with retrospective analyses of surveillance data from 2016 to 2024 to better understand the transmission dynamics and assess the effectiveness and reliability of the rabies surveillance system on Unguja Island. Towards this goal, rabies RNA was extracted from used lateral flow devices for further molecular phylogenetic analyses of the partial nucleoprotein gene. From this analysis, we were able to conclude that the rabies lyssaviruses presently circulating on Unguja Island represent a distinct endemic cycle in comparison to rabies viruses from elsewhere in Tanzania. In addition, space-time analysis and the evaluation of testing rates identified high-risk rabies areas with particularly inadequate surveillance. These findings allow better understandings of the disease's impact, which will support improved surveillance and the implementation of targeted control strategies, and will pave the way for, hopefully, the elimination of dog rabies in the longer run.
Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study.
Cuella-Martin I, Hakizayezu F, Mulders W, Niyompano H, Runyambo D, Keysers J, De Rijk WB, Habimana Mucyo Y, Migambi P, Muvunyi CM, Meehan CJ, de Jong BC, Rigouts L, Ngabonziza JCS, Mitchell E · BMJ Open (2026)
Rwanda · DOI: 10.1136/bmjopen-2025-111823
Approximately 96% of rifampicin resistance/multidrug-resistant tuberculosis (RR/MDR-TB) cases in Rwanda result from direct transmission rather than acquired resistance. However, the nationwide spatial distribution and transmission dynamics of RR/MDR-TB remain poorly characterised. This study aims to analyse spatial patterns of RR/MDR-TB in Rwanda and explore relationships between spatial proximity and RR/MDR-TB strains' genetic relatedness.
We conducted a retrospective analysis of 249 confirmed RR-TB cases across Rwanda from 2017 to 2024, using the known geolocations of patients' residences. Spatial and space-time clustering was assessed using Kulldorff's scan statistics. Demographic and socioeconomic determinants were evaluated using multivariable regression. For 201 cases with whole-genome sequencing data, we performed transmission analysis using a 5-SNP threshold to define recent transmission clusters and investigated spatial relationships within genetically related strains.
Significant spatial clustering of RR/MDR-TB was identified in 21 sectors, mainly in Nyarugenge, southern Gasabo and western Kicukiro (relative risk: 10.06; p<0.001). Our multivariable analysis showed that population density is positively associated with case notification rates. Molecular analysis revealed 88.5% of cases belonged to genotype clusters defined using a 12-SNP threshold, with 73.6% forming clusters at a strict 5-SNP threshold. Spatial K-function analysis of the six major clusters revealed heterogeneous transmission patterns, characterised by both tightly clustered outbreaks and regional transmission networks that spanned administrative boundaries. Most clusters (5/6) extended beyond Kigali, indicating that transmission networks operate across administrative divides.
RR/MDR-TB in Rwanda shows significant spatial clustering with transmission occurring through both localised and regional networks. Integrating genomic and spatial data reveals transmission patterns that extend beyond household contacts and administrative boundaries. These findings underscore the need to implement geographically targeted interventions that address community-level transmission to control RR/MDR-TB in Rwanda effectively.
rMAP-Candida: a modular Dockerized WDL/Cromwell workflow for reproducible Candida species typing, assembly-contiguity assessment, antifungal-resistance marker screening, and phylogenomic surveillance.
Mboowa G, Sserwadda I, Kanyerezi S, Kidenya BR, Bwambale J, Musinguzi B · Front Bioinform (2026)
Uganda · DOI: 10.3389/fbinf.2026.1896572
Candida spp. infections are an increasing public health concern, particularly in settings where laboratory mycology, genomic surveillance infrastructure, and antifungal susceptibility testing remain limited. Accurate species identification, reproducible assembly assessment, conservative genomic screening for antifungal-resistance markers, and interpretable phylogenomic outputs are essential for surveillance and outbreak preparedness. However, fungal whole-genome sequencing workflows remain fragmented, difficult to reproduce across computing environments, and insufficiently adapted for implementation in low-resource public health genomics settings.
We developed rMAP-Candida, a modular, Dockerized WDL/Cromwell workflow for paired-end Candida spp. whole-genome sequencing analysis. The workflow performs read quality control and trimming with fastp, Candida-focused species typing using Kraken2/Bracken, de novo assembly with MEGAHIT, assembly-contiguity assessment with QUAST, optional genome-completeness assessment using Compleasm or BUSCO, antifungal-resistance marker screening using ChroQueTas/FungAMR-derived outputs, species-aware core-SNP phylogenomics, pairwise SNP-distance summarization, closest-neighbor analysis, and integrated HTML surveillance reporting. To improve independent reproducibility, the repository includes a quick-start local Cromwell test, a corrected two-sample input JSON, documented checks for public container and database access, and a two-sample reproducibility run.
rMAP-Candida generated reproducible species assignments, assembly-contiguity metrics, optional completeness summaries, antifungal-resistance marker outputs, species-aware phylogenomic summaries, pairwise SNP-distance tables, closest-neighbor summaries, and integrated HTML reports. In the Ugandan validation dataset, the workflow identified six principal species groups, dominated by Candida albicans, followed by Candida tropicalis, Pichia kudriavzevii, Nakaseomyces glabratus, Clavispora lusitaniae, and Candida parapsilosis. The integrated report summarized 24 antifungal-resistance marker hits and a median assembly N50 of 35,946 bp. Species-aware phylogenomics was performed for eligible species groups, while ineligible or skipped groups were explicitly reported with reasons. The report also distinguished "no curated genomic antifungal-resistance marker detected" from phenotypic susceptibility, supporting conservative interpretation of resistance-screening outputs.
rMAP-Candida provides a portable, reproducible, modular, and surveillance-oriented WDL/Cromwell workflow for Candida spp. genomic analysis. By integrating species identification, assembly-contiguity assessment, optional completeness evaluation, antifungal-resistance marker screening, species-aware phylogenomics, SNP-distance summarization, closest-neighbor reporting, and HTML reporting, the workflow supports training, research, and applied fungal genomic surveillance in low-resource and other implementation settings.
From forests to deserts: Sequencing of the giant forest hog completes the genomic history of the African suids.
Ciucani MM, Aninta SG, Gomes Martins NF, Duchêne DA, Wang X, Lazagabaster IA, Liu X, Stæger FF, Schubert M, Bøggild T, He S, Li Z, Reyna R, Meijaard E, Butynski TM, Muwanika VB, Masembe C, Dufour S, Gaubert P, Siegismund HR, Moltke I, Albrechtsen A, Heller R · iScience (2026)
Uganda · DOI: 10.1016/j.isci.2026.117121
The giant forest hog (GFH; Hylochoerus meinertzhageni), the largest and most elusive wild pig, is found in a disjunct range across tropical Africa, from Guinea to the Ethiopian highlands. The GFH has three morphologically defined subspecies. Here, we present the first whole-genome data for nine samples from Guinea and Uganda, its two most geographically distant subspecies. We identify the GFH as sister to warthogs among African suids, diverging around 4.6 Mya, with the two GFH populations splitting between 1.7 and 0.5 Mya and following distinct demographic trajectories. The deep evolutionary split is confirmed by species-level genetic differentiation and the lowest heterozygosity level in the Guinean population compared with all the African suids, likely reflecting long-term low effective population size and isolation. Our findings have implications for understanding the habitat-change consequences in African rainforests and reveal a deep evolutionary divergence within the GFH with potential conservation relevance.